Sera Prognostics SG&A Expenses 2021-2024 | SERA
Sera Prognostics sg&a expenses from 2021 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Sera Prognostics Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $25 |
| 2022 | $31 |
| 2021 | $24 |
| 2020 | $10 |
| Sera Prognostics Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $5 |
| 2023-12-31 | $5 |
| 2023-09-30 | $5 |
| 2023-06-30 | $8 |
| 2023-03-31 | $7 |
| 2022-12-31 | $7 |
| 2022-09-30 | $7 |
| 2022-06-30 | $9 |
| 2022-03-31 | $9 |
| 2021-12-31 | $9 |
| 2021-09-30 | $7 |
| 2021-06-30 | $5 |
| 2021-03-31 | $4 |
| 2020-12-31 | |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.300B | $0.000B |
| Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.315B | 15.72 |
| Cencora (COR) | United States | $44.797B | 17.47 |
| ICON (ICLR) | Ireland | $26.018B | 24.56 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| Avantor (AVTR) | United States | $16.839B | 24.79 |
| CochLear (CHEOY) | Australia | $13.827B | 0.00 |
| Viatris (VTRS) | United States | $13.288B | 3.97 |
| Revvity (RVTY) | United States | $12.932B | 22.68 |
| Natera (NTRA) | United States | $12.715B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.253B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.089B | 39.77 |
| Charles River Laboratories (CRL) | United States | $11.751B | 22.50 |
| Solventum (SOLV) | United States | $10.996B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.479B | 0.00 |
| HealthEquity (HQY) | United States | $6.635B | 49.57 |
| Bausch + Lomb (BLCO) | Canada | $5.415B | 21.70 |
| Organon (OGN) | United States | $5.251B | 4.98 |
| Doximity (DOCS) | United States | $4.360B | 32.46 |
| PACS (PACS) | United States | $3.734B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.379B | 30.92 |
| Sotera Health (SHC) | United States | $3.125B | 15.33 |
| Life Times (LTH) | United States | $2.905B | 30.44 |
| Progyny (PGNY) | United States | $2.646B | 45.13 |
| GoodRx Holdings (GDRX) | United States | $2.607B | 94.29 |
| Premier (PINC) | United States | $2.336B | 8.74 |
| Agilon Health (AGL) | United States | $2.134B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.073B | 8.24 |
| Teladoc Health (TDOC) | United States | $2.027B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.926B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.772B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.537B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.306B | 0.00 |
| Embecta (EMBC) | United States | $0.820B | 5.58 |
| CareDx (CDNA) | United States | $0.768B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.701B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.692B | 7.34 |
| InnovAge Holding (INNV) | United States | $0.555B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.542B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.537B | 0.00 |
| MultiPlan (MPLN) | United States | $0.455B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.418B | 41.70 |
| LifeMD (LFMD) | United States | $0.394B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.98 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| DocGo (DCGO) | United States | $0.315B | 16.78 |
| Sharecare (SHCR) | United States | $0.280B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Oncology Institute (TOI) | United States | $0.069B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |